Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma

作者：Pappa C A; Tsirakis G; Psarakis F E; Kolovou A; Tsigaridaki M; Stafylaki D; Sfiridaki K; Alexandrakis M G^*

来源：Medical Oncology, 2013, 30(1): 363.

DOI：10.1007/s12032-012-0363-0

• Multiple myeloma
• Insulin-like growth factor-1
• Cytokines
• Angiogenesis

There are many growth factors influencing the expansion of multiple myeloma (MM). Angiogenesis is a process that may enhance MM growth, in various manners. Among them, insulin-like growth factor-1 (IGF-1) is a major factor, acting in many levels. The aim of the study was to measure serum levels of IGF-1 in newly diagnosed MM patients and to correlate them with clinical stage of the disease and with markers of angiogenesis, such as vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and interleukin-6 and 15 (IL-6 and IL-15). Serum levels of the above factors were measured, by ELISA, in 57 newly diagnosed MM patients and in 20 healthy controls. There was no difference in serum levels of IGF-1 in MM patients and in controls, contrary to angiogenic factors, which were higher in MM patients (p < 0.001). Similarly, IGF-1 did not correlate with clinical stage of the disease nor the other angiogenic factors, which also correlated with each other (p < 0.001). Serum IGF-1 concentrations are not influenced in MM patients. Therefore, although it is a proliferation cytokine, it cannot be used as marker of disease activity.

• 出版日期2013-3